| Accession Number: | 0001209191-23-046024 |
| Date: | 2023-08-14 |
| Issuer: | CRINETICS PHARMACEUTICALS, INC. (CRNX) |
| Original Submission Date: |
STRUTHERS RICHARD SCOTT
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO, CA 92121
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-08-14 | M | 10,000 | a | $1.91 | 135,522 | direct | ||
| COMMON STOCK | 2023-08-14 | 0 | $0.00 | 630,805 | indirect | ||||
| COMMON STOCK | 2023-08-14 | 0 | $0.00 | 1,000 | indirect | ||||
| COMMON STOCK | 2023-08-14 | 0 | $0.00 | 90,000 | indirect | ||||
| COMMON STOCK | 2023-08-14 | 0 | $0.00 | 90,000 | indirect | ||||
| COMMON STOCK | 2023-08-14 | 0 | $0.00 | 90,000 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INCENTVE STOCK OPTION (RIGHT TO BUY) | 1.91 | 2023-08-14 | deemed execution date | M | 10,000 (d) | 2028-03-16 | common stock 10,000 | $1.91 | 151,270 | direct |
| ID | footnote |
|---|---|
| f1 | 1/48th of the shares subject to the option vested on april 16, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date. |
